Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zydus Wellness Limited (ZYDUSWELL.NS)
Ahmedabad, IN
Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Natura, and Sugar Free Green. The company also offers well-known beverages like Complan, a milk-based health drink, and Glucon D, a glucose-infused refreshment, alongside Sugarlite, a unique blend of sugar and stevia. In the personal care segment, Zydus Wellness markets the Everyuth brand, featuring skincare items such as soap-free face washes, masks, scrubs, and cleansers. The Nycil brand provides solutions for prickly heat, cooling powders, and hand sanitizers. Furthermore, their Nutralite line includes a diverse array of spreads, from probiotic butter and table spreads to ghee, butter, cholesterol-fat-free spreads, mayonnaise, and chocolate spreads. Beyond its domestic operations in India, Zydus Wellness actively exports its offerings. Tracing its origins to 1988, the Ahmedabad, India-based entity was initially known as Carnation Nutra Analogue Foods Limited before adopting its current name, Zydus Wellness Limited, in January 2009. It operates as a subsidiary of Cadila Healthcare Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.71% | -2.23% | +1.97% | +27.18% | +11.72% | +11.99% | +38.90% | +73.82% | +20.54% | +225.03% | +1,169.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | -1 |
| Hold | 2 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+46.2% ★ Q1'26: +63.0% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%-43.1% Q1'26: -81.2% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+1.5% Q1'26: +1.6% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+9.0% ★ Q1'26: +14.1% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+3.4% Q1'26: +8.6% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+399.9% Q1'26: +400.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×6.38× Q1'26: 3.02× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 8 Rev. Ana. 7 EPS Ana. |
Mar 2027 8 Rev. Ana. 7 EPS Ana. |
Mar 2028 8 Rev. Ana. 7 EPS Ana. |
Mar 2029 4 Rev. Ana. 4 EPS Ana. |
Mar 2030 4 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.36B
est: 3.45B (-2.5%)
|
3.35B
est: 3.50B (-4.2%)
|
3.87B
est: 3.62B (+7.0%)
|
4.03B
est: 4.25B (-5.1%)
|
4.21B
est: 4.29B (-1.9%)
|
3.95B
est: 4.37B (-9.7%)
|
4.27B
est: 4.55B (-6.0%)
|
5.01B
est: 5.08B (-1.3%)
|
8.08B
est: 6.17B (+31.0%)
|
17.66B
est: 18.08B (-2.3%)
|
18.67B
est: 18.23B (+2.4%)
|
20.09B
est: 20.15B (-0.3%)
|
22.55B
est: 22.66B (-0.5%)
|
23.28B
est: 23.32B (-0.2%)
|
27.09B
est: 26.77B (+1.2%)
|
39.57B
38.44B – 40.34B
+47.8% YoY
|
53.29B
50.27B – 55.24B
+34.7% YoY
|
60.55B
56.63B – 62.51B
+13.6% YoY
|
68.14B
63.99B – 70.48B
+12.5% YoY
|
75.39B
70.80B – 77.99B
+10.6% YoY
|
| EBITDA |
2.06B
est: 498.11M (+312.9%)
|
861.30M
est: 991.78M (-13.2%)
|
1.12B
est: 915.40M (+22.7%)
|
1.08B
est: 1.48B (-26.9%)
|
1.27B
est: 1.28B (-0.6%)
|
1.24B
est: 1.54B (-19.7%)
|
1.32B
est: 1.59B (-17.1%)
|
1.60B
est: 1.82B (-12.1%)
|
2.13B
est: 2.18B (-2.2%)
|
2.88B
est: 5.94B (-51.6%)
|
2.21B
est: 186.13M (+1,088.2%)
|
3.55B
est: 219.05M (+1,521.3%)
|
3.32B
est: 243.90M (+1,261.0%)
|
3.08B
est: 279.28M (+1,002.5%)
|
3.99B
est: 3.87B (+3.2%)
|
5.71B
5.55B – 5.83B
+47.7% YoY
|
7.70B
7.26B – 7.98B
+34.7% YoY
|
8.74B
8.18B – 9.03B
+13.6% YoY
|
9.84B
9.24B – 10.18B
+12.5% YoY
|
10.89B
10.22B – 11.26B
+10.6% YoY
|
| EBIT |
2.04B
est: 458.77M (+345.0%)
|
822.70M
est: 851.20M (-3.3%)
|
1.08B
est: 717.54M (+50.3%)
|
1.04B
est: 1.08B (-4.2%)
|
1.20B
est: 873.72M (+37.0%)
|
1.17B
est: 934.28M (+25.0%)
|
1.24B
est: 871.78M (+42.8%)
|
1.51B
est: 1.04B (+45.5%)
|
2.01B
est: 1.34B (+50.0%)
|
2.61B
est: 5.03B (-48.2%)
|
1.96B
est: 2.45B (-20.2%)
|
3.31B
est: 2.88B (+14.8%)
|
3.07B
est: 3.21B (-4.4%)
|
2.84B
est: 3.68B (-22.8%)
|
3.71B
est: 3.56B (+4.0%)
|
5.26B
5.11B – 5.37B
+47.7% YoY
|
7.09B
6.69B – 7.35B
+34.7% YoY
|
8.05B
7.53B – 8.32B
+13.6% YoY
|
9.06B
8.51B – 9.38B
+12.5% YoY
|
10.03B
9.42B – 10.37B
+10.6% YoY
|
| Net Income |
594.80M
est: 1.04B (-42.9%)
|
676.80M
est: 604.17M (+12.0%)
|
971.10M
est: 659.65M (+47.2%)
|
964.50M
est: 1.14B (-15.4%)
|
1.09B
est: 989.55M (+10.1%)
|
1.03B
est: 1.10B (-6.5%)
|
1.09B
est: 1.07B (+2.3%)
|
1.34B
est: 1.23B (+8.6%)
|
1.69B
est: 1.54B (+9.8%)
|
1.42B
est: 5.28B (-73.1%)
|
1.19B
est: 1.39B (-14.4%)
|
3.09B
est: 1.63B (+89.2%)
|
3.10B
est: 1.82B (+70.8%)
|
2.67B
est: 2.08B (+28.3%)
|
3.47B
est: 3.63B (-4.6%)
|
2.51B
1.82B – 3.29B
-31.0% YoY
|
4.06B
3.11B – 5.37B
+62.2% YoY
|
5.24B
4.57B – 6.53B
+29.0% YoY
|
6.42B
5.92B – 6.71B
+22.6% YoY
|
8.59B
7.91B – 8.97B
+33.7% YoY
|
| SGA |
1.32B
est: 640.74M (+105.9%)
|
930.10M
est: 1.33B (-29.9%)
|
1.13B
est: 1.19B (-5.1%)
|
1.25B
est: 1.91B (-34.4%)
|
1.35B
est: 1.90B (-28.6%)
|
1.21B
est: 1.97B (-38.7%)
|
1.09B
est: 1.76B (-37.8%)
|
1.25B
est: 2.07B (-39.7%)
|
2.10B
est: 2.41B (-13.1%)
|
3.72B
est: 10.62B (-64.9%)
|
3.84B
est: 6.02B (-36.1%)
|
3.92B
est: 7.08B (-44.7%)
|
4.44B
est: 7.89B (-43.7%)
|
2.62B
est: 9.03B (-71.0%)
|
5.92B
est: 10.36B (-42.9%)
|
7.35B
7.14B – 7.50B
-29.1% YoY
|
9.90B
9.34B – 10.26B
+34.7% YoY
|
11.25B
10.52B – 11.61B
+13.6% YoY
|
12.66B
11.89B – 13.09B
+12.5% YoY
|
14.01B
13.15B – 14.49B
+10.6% YoY
|
| EPS |
15.22
est: 16.36 (-7.0%)
|
17.32
est: 16.74 (+3.4%)
|
24.85
est: 22.22 (+11.8%)
|
24.69
est: 27.14 (-9.0%)
|
27.88
est: 25.32 (+10.1%)
|
26.43
est: 5.27 (+401.3%)
|
27.89
est: 5.74 (+385.9%)
|
34.27
est: 6.50 (+427.2%)
|
40.10
est: 6.89 (+481.8%)
|
24.58
est: 4.67 (+426.3%)
|
3.91
est: 5.11 (-23.5%)
|
9.71
est: 9.68 (+0.4%)
|
9.76
est: 10.12 (-3.6%)
|
8.39
est: 9.06 (-7.4%)
|
10.90
est: 11.33 (-3.8%)
|
7.88
5.73 – 10.35
-30.4% YoY
|
12.78
9.77 – 16.89
+62.2% YoY
|
16.48
14.35 – 20.54
+29.0% YoY
|
20.20
18.60 – 21.10
+22.6% YoY
|
27.00
24.86 – 28.21
+33.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.85M | 0.06% |
| 2 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 6.72M | 0.06% |
| 3 | Vanguard ESG International Stock ETF VSGX | 0.00% | 136.3K | 0.10% |
| 4 | Vanguard Total International Stock ETF VXUS | 0.00% | 7.33M | 0.05% |
| 5 | Vanguard Total World Stock ETF VT | 0.00% | 320.0K | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Umesh V. Parikh | Chief Financial Officer | 12M | male |
| Arijit Sengupta | Chief Marketing Officer | — | male |
| Bhupesh Desale | Head of Neo Foods Vertical | — | male |
| Manish Lal | Head of Global Demand & Supply Organization | — | male |
| Adhir Anand | Head of Media & Digital | — | male |
| Rajeev Anand | Principal Officer | — | male |
| Tarun G. Arora | Chief Executive Officer & Whole Time Director | — | male |
| Nandish Joshi | Company Secretary & Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZYDUSWELL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
